Carlyle Credit Income Fund's NAV Insights and Latest Developments
Understanding Carlyle Credit Income Fund's Latest NAV Report
Carlyle Credit Income Fund (NYSE: CCIF) has recently unveiled its unaudited net asset value (NAV) per common share, reporting this figure as $7.64. This information was shared through a filing with the Securities and Exchange Commission, indicating the fund's current fiscal status. The announcement is important for investors, offering a glimpse into the health and value of the fund.
The Significance of NAV Calculation
The NAV is a pivotal metric for investment funds, as it provides a clear picture of the company's overall worth. By dividing the total net asset value of the fund by the number of shares outstanding, investors can better understand their investment's value. The recent NAV per share figure underscores Carlyle Credit Income Fund's ongoing performance and offers investors insight into their potential returns.
Carlyle Credit Income Fund's Historical Context
This fund, formerly recognized as the Vertical Capital Income Fund, is incorporated in Delaware and proudly trades on the New York Stock Exchange under the ticker symbol CCIF. The company also offers preferred shares labeled under the ticker CCIAN, catering to a broader range of investors looking for diverse investment opportunities.
Exploring Recent Developments and Financial Performance
Carlyle Credit Income Fund remains active in the Collateralized Loan Obligation (CLO) marketplace, with reports confirming that it has maintained a quarterly dividend of $0.105 per share through November. This consistent dividend payout showcases the fund's commitment to rewarding its shareholders.
Moreover, the fund has engaged in a private placement of its 7.125% Series B Convertible Preferred Shares, which are expected to raise approximately $10.6 million. It is also in the process of executing a registered direct placement of 1,444,865 common shares, anticipated to generate around $11.5 million in proceeds. Such strategic movements demonstrate the fund's proactive approach to enhancing its financial position.
In terms of investment performance, Carlyle Credit Income Fund has made noteworthy strides, with new CLO investments amounting to $12.2 million. With an impressive weighted average GAAP yield of 19.5%, the fund's overall investment income for the third quarter reached $7.4 million. Additionally, the fund successfully raised $5.5 million through its At-The-Market (ATM) program. The fund's portfolio continues to perform robustly, exhibiting a GAAP yield of 20.26% based on its cost and a junior overcollateralization cushion of 4.17%.
Insights on Dividend Performance
Recent insights reveal that Carlyle Credit Income Fund boasts an attractive dividend yield of 15.05%, with its most recent ex-dividend date recorded as September 18, 2024. This data reinforces the fund's history of consistent dividend payments, having maintained this for 13 consecutive years—a testament to its commitment to delivering value to shareholders.
Market Performance and Stock Valuation
As of the latest update, Carlyle Credit Income Fund's stock price stood at $8.37, which represents 95.34% of its 52-week high. This suggests that the fund's performance has been solid in recent times. Positive returns further corroborate this strength, with total returns of 22.85% over the past year and 18.06% year-to-date, marking it as a noteworthy investment option.
Further Analysis Available
For investors looking for deeper insights and analysis, Carlyle Credit Income Fund has numerous resources available. These insights can help in making informed investment decisions, adding layers of understanding regarding the fund’s financial health and market performance.
Frequently Asked Questions
What is the current NAV per share for Carlyle Credit Income Fund?
The unaudited NAV per share for Carlyle Credit Income Fund is currently reported as $7.64.
What dividends has Carlyle Credit Income Fund been paying recently?
The fund has maintained a quarterly dividend of $0.105 per share through November.
How active is Carlyle Credit Income Fund in the CLO market?
Carlyle Credit Income Fund has recently engaged in CLO investments totaling $12.2 million, showcasing its active participation in this market.
What is the historical yield of Carlyle Credit Income Fund?
The fund currently boasts a dividend yield of 15.05%, reflecting its commitment to shareholder returns.
What has been the stock performance of Carlyle Credit Income Fund?
The stock price is at $8.37, representing 95.34% of its 52-week high, with positive total returns observed over the last year.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- H2O.ai Partners with AI Verify for AI Accountability and Safety
- Vivance Emerges: Redefining Kidney Care with a Fresh Brand
- Hyundai Motor Group and NTU Collaborate for Carbon Neutrality
- Market Dynamics: Tech and Fed Policies Shape Future Outlook
- Disturbing Allegations Surface Against OBGYN and Medical Centers
- Industry Leaders to Discuss Future of Broadband at Expo
- Understanding the Rising Cyber Threats in Healthcare Today
- Eagle Point Institutional Income Fund Announces New Offering
- Spanish-language TV Ads Surge Ahead, Revealing New Insights
- U.S. Holiday Shopping Trends: Earlier Starts and Increased Spending
Recent Articles
- Hilton Grand Vacations Launches $400M Term Loan A Offering
- Unusual Machines Takes Strategic Steps in Stock Issuance and Bylaws
- Albertsons Companies Prepares for Fiscal 2024 Earnings Release
- Cardiol Therapeutics Boldly Pursues Growth with New Offering
- Lamar Advertising Set to Reveal Q3 Results with Insights
- Extreme Networks to Announce Q1 2025 Financial Results Call
- Hurricane Milton: The Increased Burden on FEMA's Resources
- Piedmont Office Realty Trust Announces Q3 2024 Earnings Call
- SkyWater Technology Set to Release Third Quarter Earnings Soon
- Fed Boston President Predicts Potential Rate Cuts Ahead
- Kite Realty Securely Major Financial Amendments for Growth
- MasterBrand Set to Reveal Q3 2024 Financial Results Soon
- Exploring Why ON Semiconductor Could Be Your October Investment
- Vishay Intertechnology's Upcoming Third Quarter Results Announcement
- Amneal Pharmaceuticals Sets Date for Q3 2024 Earnings Report
- Seagate Technology Set to Unveil Fiscal Q1 Results Soon
- Key Insights on Badger Infrastructure's Upcoming Q3 2024 Results
- Electronic Arts to Reveal Fiscal Q2 2025 Financials Soon
- Waldorf Astoria Orlando Shines as a Top Global Hotel Choice
- Armada Hoffler Schedules Key Date for Q3 2024 Financials
- DigitalOcean to Report Q3 2024 Earnings and Host Call
- AOC Pharma S.à r.l. Updates Stakeholding in Fagron NV
- Enhabit Home Health Announces Upcoming Earnings Call Details
- MetLife Reports Fourth Quarter Dividend for Shareholders
- PrairieSky Royalty Sets Date for Q3 Financial Results Call
- Understanding the Transformative Role of Placental Tissue for Healing
- The Arena Group Faces NYSE Compliance Challenge: Next Steps
- Rhythm Pharmaceuticals Expands Team with New Stock Grants
- Terreno Realty Corporation Reports Q3 Performance and Developments
- How a Young Investor Boosted Their Dividend Income Effectively
- Crinetics Pharmaceuticals Pursues $400 Million Stock Offering
- Investigation Launched into Stitch Fix, Inc. Financial Results
- TC Energy Corporation Cash Tender Offers: Key Insights
- Nvidia's Promising Surge: What Investors Should Know
- WM Technology Faces SEC Investigation: What Investors Should Know
- ImmuCell Reports Strong Q3 2024 Sales Growth and Strategic Moves
- Investigation Launched into Acadia Healthcare Company Amid Concerns
- Innovative Collaboration: Triton Digital and NZME's Audio Future
- T2 Biosystems Announces Upcoming Business Update Call Details
- Rani Therapeutics Highlights Innovations at Upcoming Virtual Summit
- Opportunity for Bumble Inc. Investors to Join Class Action Suit
- Bumble Inc. Investors: Join Class Action Lawsuit Now!
- Elcora Markets Update: Management Cease Trade Order Status
- Investigation Launched into Medpace Holdings, Inc. by Legal Firm
- Opportunity for Super Micro Computer Investors Amid Legal Action
- Hanmi Financial Unveils Q3 2024 Earnings and Upcoming Call
- Profiting from Ascendis Pharma: A 10-Year Investment Journey
- HBT Financial Sets Date for Q3 2024 Financial Results Release
- Investor Inquiry into 2seventy bio, Inc. Raises Concerns
- Transform Your $1,000 Investment into Over $2,100 Today!